Back to search
FDAFDA · Food and drugs·Recall number Z-2225-2021

MYLA software. Used to manage microbiology test workflow from the reception of requests to the transmission of results by transferring, storing, and displaying medical device data.

Published August 18, 2021 · Recall initiated: June 22, 2021

Summary

FDA records medical device Class II recall Z-2225-2021, published August 18, 2021 and initiated June 22, 2021. Recalling firm: BioMerieux SA; Status: Terminated; Reported quantity: 248 systems; Lot: MYLA V4.8.0/4.8.1 and MYLA V4.7.0/V4.7.1 in conjunction with BCI CONNECT, UDI 03573026619244 and 03573026610975. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Software anomaly - Under certain conditions, unwanted alterations to results could be applied when using the BCI Connect scripting feature.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
BioMerieux SA
Distributor
Distribution in the U.S. was nationwide. There was also military and government distribution.
Lot
MYLA V4.8.0/4.8.1 and MYLA V4.7.0/V4.7.1 in conjunction with BCI CONNECT, UDI 03573026619244 and 03573026610975.
Risk classification
Class II
Area (FDA)
device
Country
France

Related recalls

Questions about this recall

Was MYLA software. Used to manage microbiology test workflow from the reception of requests to the transmission of results by transferring, storing, and displaying medical device data. recalled?

Yes. FDA published recall Z-2225-2021 on August 18, 2021. Reported hazard: Software anomaly - Under certain conditions, unwanted alterations to results could be applied when using the BCI Connect scripting feature.

What should I do if I have this product?

Voluntary: Firm initiated · Letter